Xin Li
Hebei Medical University(CN)Shanghai Medical College of Fudan University(CN)Sun Yat-sen University(CN)Tianjin University(CN)Northeast Agricultural University(CN)Shanghai Jiao Tong University(CN)Shanghai University of Sport(CN)Gas Turbine Research Establishment(IN)Chinese Academy of Sciences(CN)Peking University(CN)Sichuan University(CN)XinHua Hospital(CN)Ruijin Hospital(CN)Chinese PLA General Hospital(CN)Beijing Jishuitan Hospital(CN)Wuhan University(CN)Shanghai Children's Medical Center(CN)Fudan University Shanghai Cancer Center(CN)Jinzhong University(CN)Shanghai University of Traditional Chinese Medicine(CN)BeiGene (China)(CN)Integrated Chinese Medicine (China)(CN)Fourth Hospital of Hebei Medical University(CN)Hunan Cancer Hospital(CN)Zhongnan Hospital of Wuhan University(CN)Shanghai Institute of Applied Physics(CN)Shanghai East Hospital(CN)Peking University Shenzhen Hospital(CN)Yueyang Hospital(CN)181st Hospital of Chinese People's Liberation Army(CN)Shanghai Traditional Chinese Medicine Hospital(CN)Shanxi University of Traditional Chinese Medicine(CN)Southern Medical University Shenzhen Hospital(CN)Guangdong Academy of Medical Sciences(CN)Third Affiliated Hospital of Sun Yat-sen University(CN)Tianjin Chest Hospital(CN)Institute of Mechanics(CN)Xijing Hospital(CN)Shanghai Children's Hospital(CN)University of Chinese Academy of Sciences(CN)Wuhan University of Science and Technology(CN)Tianjin Medical University(CN)Southern Medical University(CN)Nanjing University(CN)Air Force Medical University(CN)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Connective Tissue Growth Factor Research
Most-Cited Works
- → WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment(2019)279 cited
- → Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma(2018)195 cited
- → Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis(2019)145 cited
- → The Relative Risk and Incidence of Immune Checkpoint Inhibitors Related Pneumonitis in Patients With Advanced Cancer: A Meta-Analysis(2018)142 cited
- → Exosomal ncRNAs: Novel therapeutic target and biomarker for diabetic complications(2022)132 cited
- → Dynamic Changes in Amino Acid Concentration Profiles in Patients with Sepsis(2015)130 cited